Medytox (086900.KQ) participated in an international conference hosted by the Korean Society for Laser Medicine and Surgery, sharing procedural expertise and clinical data on its key aesthetic medical products as part of its marketing activities.
Medytox announced Thursday that it had successfully concluded its participation in the "52nd Spring International Congress of the Korean Society for Laser Medicine and Surgery," held on Sunday at COEX in Seoul. The conference drew more than 5,000 medical professionals from Korea and abroad.
The company set up the largest exhibition booth at the venue to present its main product lineup. It introduced "Coretox," a 150 kilodalton (kDa) botulinum toxin product, and "Innotox," a non-animal-derived liquid formulation suited for combination procedures with energy-based devices (EBD). Medytox also promoted its broader toxin portfolio, including "Newlux" from affiliate Neumeco, which is accelerating its overseas expansion. The company additionally highlighted its hyaluronic acid fillers "Neuramis" and "Atiere," along with its recently launched "Newvisu," the world's first fat-reduction injectable based on cholic acid.
Lectures were also held to share the latest aesthetic procedure trends centered on Medytox products. Kim Hyung-moon, director of the Apgujeong branch of Meilin Clinic, unveiled the latest research results demonstrating the high thermal stability of Innotox and shared insights on combination procedures using EBD and botulinum toxin products. Heo Su-jung, director of Magma Clinic, introduced a neck wrinkle treatment method using "Neuramis Skin Enhancer" and mesotherapy needles. O Myung-jun, director of O&n Clinic, then presented shoulder contouring procedure techniques using "Neuramis Heart."
In addition, Kim Hoon-young, director of Pagmarion Clinic, lectured on the distinct features of Medytox's botulinum toxin products; Kim Jin-oh, director of NewHair Hair Transplant Clinic, presented hair loss treatments using "Coretox"; and Lee Seo-hyun, director of Le Medique Clinic, delivered a clinical-focused lecture on face and body contouring strategies using "Newlux," drawing strong interest from attendees.
"At this conference, we shared procedural expertise and clinical data using Medytox's key products and confirmed the high level of interest from the medical field," a Medytox official said. "We will expand various marketing activities to more effectively communicate our product competitiveness."
